Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Catheter Precision, Inc.

  • FORT MILL, South Carolina
  • Public · NYSE: VTAK
  • 17 employees
$2.8MMarket cap
$819.0KRevenue · FY2025
-$17.2MNet income
17Employees
VTAKNYSE
2018IPO

About Catheter Precision, Inc.

Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$819.0K
Net income
-$17.2M
Total assets
$15.9M
Market cap
$2.8M

Source: SEC EDGAR · updated Jun 8, 2026

NYSE: VTAK

15-minute delayed · data by Polygon.io

Market cap
$2.8M
Open
Day range
Prev close
Volume
IPO date
Sep 27, 2018

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review Catheter Precision, Inc..

Write a review
Explore

Similar companies

Browse all →